Kimford Meador, MD, FAAN, Stanford University, Stanford, CA, discusses the importance of precision medicine and improved biological understanding in women with epilepsy. A deeper knowledge of the impact of genetics on treatment effects and risks is critical to improving epilepsy management, particularly in relation to pregnancy. For example, the genotypes at risk for antiseizure medication-induced teratogenic deficits are not well understood. Substantial variability in neurodevelopmental outcomes in children of women with epilepsy suggests many other factors may impact pregnancy outcomes and further investigation is needed. This interview took place during the American Academy of Neurology (AAN) 2021 Annual Meeting.